SEC Comment Letter 0000000000-25-003101 to Bon Natural Life Ltd (BON)
Bon Natural Life Ltd
Date: March 24, 2025 · CIK: 0001816815 · Accession: 0000000000-25-003101
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-40517
Letter
Re: Bon Natural Life Limited Form 20-F for Fiscal Year Ended September 30, 2024 File No. 001-40517 Dear Wallace Lee:
March 24, 2025
Wallace Lee Chief Financial Officer Bon Natural Life Limited Room 601, Block C, Gazelle Valley , No.69, Jinye Road High-Tech Zone , Xi an , Shaanxi, China People s Republic of China
We have reviewed your filing and have the following comment.
Please respond to this letter within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe a comment applies to your facts and circumstances, please tell us why in your response.
After reviewing your response to this letter, we may have additional comments. March 24, 2025 Page 2 Form 20-F for Fiscal Year Ended September 30, 2024 Item 3. Key Information Holding Foreign Companies Accountable Act, page 3
1. We note your disclosure on page 3 that [yo]ur auditor, located in China, is subject to the 2021 Determination Report appears to conflict with your disclosure on the same page stating your auditor is a U.S.-based accounting firm that is registered with the PCAOB and was not subject to the 2021 Determination Report. Please revise to reconcile your disclosure or otherwise advise. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tara Harkins at 202-551-3639 or Lynn Dicker at 202-551-3616 if you have questions regarding comments on the financial statements and related matters. Please contact Daniel Crawford at 202-551-7767 or Laura Crotty at 202-551-7614 with any other questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> March 24, 2025 Wallace Lee Chief Financial Officer Bon Natural Life Limited Room 601, Block C, Gazelle Valley , No.69, Jinye Road High-Tech Zone , Xi an , Shaanxi, China People s Republic of China Re: Bon Natural Life Limited Form 20-F for Fiscal Year Ended September 30, 2024 File No. 001-40517 Dear Wallace Lee: We have reviewed your filing and have the following comment. Please respond to this letter within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe a comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to this letter, we may have additional comments. March 24, 2025 Page 2 Form 20-F for Fiscal Year Ended September 30, 2024 Item 3. Key Information Holding Foreign Companies Accountable Act, page 3 1. We note your disclosure on page 3 that [yo]ur auditor, located in China, is subject to the 2021 Determination Report appears to conflict with your disclosure on the same page stating your auditor is a U.S.-based accounting firm that is registered with the PCAOB and was not subject to the 2021 Determination Report. Please revise to reconcile your disclosure or otherwise advise. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tara Harkins at 202-551-3639 or Lynn Dicker at 202-551-3616 if you have questions regarding comments on the financial statements and related matters. Please contact Daniel Crawford at 202-551-7767 or Laura Crotty at 202-551-7614 with any other questions. Sincerely, Division of Corporation Finance Office of Life Sciences </TEXT> </DOCUMENT>